BioXcel Therapeutics (BTAI) Shares Outstanding (Entity) (2017 - 2026)
BioXcel Therapeutics (BTAI) Shares Outstanding (Entity) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | 4.44 Bn |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn | 1.17 Bn |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn | 414.15 Mn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 42.68 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 1.15 Bn |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | 101.60 Mn |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn | 499.55 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | 834.66 Mn |
| 10 | BioXcel Therapeutics | 24.73 Mn | 24.73 Mn | 160,000.00 | 31.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 31.31 Mn |
| Mar 31, 2026 | 27.08 Mn |
| Dec 31, 2025 | 12.21 Mn |
| Sep 30, 2025 | 14.20 Mn |
| Jun 30, 2025 | 6.62 Mn |
| Mar 31, 2025 | 5.47 Mn |
| Dec 31, 2024 | 2.54 Mn |
| Sep 30, 2024 | 2.65 Mn |
| Jun 30, 2024 | 2.52 Mn |
| Mar 31, 2024 | 2.10 Mn |
| Dec 31, 2023 | 1.87 Mn |
| Sep 30, 2023 | 1.83 Mn |
| Jun 30, 2023 | 1.83 Mn |
| Mar 31, 2023 | 1.82 Mn |
| Dec 31, 2022 | 1.76 Mn |
| Sep 30, 2022 | 1.75 Mn |
| Jun 30, 2022 | 1.75 Mn |
| Mar 31, 2022 | 1.75 Mn |
| Dec 31, 2021 | 1.75 Mn |
| Sep 30, 2021 | 1.75 Mn |